Skip to main content
SpringWorks Therapeutics, Inc. (SWTX)
NASDAQ: SWTX · Real-Time Price · USD
39.02
+2.72 (7.49%)
At close: Nov 22, 2024, 4:00 PM
39.90
+0.88 (2.26%)
After-hours: Nov 22, 2024, 4:02 PM EST

SpringWorks Therapeutics Revenue

SpringWorks Therapeutics had revenue of $49.30M in the quarter ending September 30, 2024. This brings the company's revenue in the last twelve months to $135.49M. In the year 2023, SpringWorks Therapeutics had annual revenue of $5.45M.

Revenue (ttm)
$135.49M
Revenue Growth
n/a
P/S Ratio
20.70
Revenue / Employee
$444,220
Employees
305
Market Cap
2.90B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20235.45M--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 202035.00M--
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Bausch Health Companies 9.47B
Surgery Partners 2.99B
Concentra Group Holdings Parent 1.88B
LivaNova 1.24B
LifeStance Health Group 1.21B
Inari Medical 574.50M
Amicus Therapeutics 493.67M
Vericel 226.84M
Revenue Rankings

SWTX News

More News